Quantcast
Last updated on April 23, 2014 at 16:13 EDT

Latest Diabetes Stories

Birth Order Linked To Weight, Insulin Resistance
2014-02-07 05:08:47

redOrbit Staff & Wire Reports - Your Universe Online First-born children could be more likely than their younger siblings to be overweight later on in life, researchers from the University of Auckland in New Zealand claim in research appearing in Thursday’s edition of the journal Scientific Reports. The study found that children who were born first into a family were approximately 7 kilograms heavier and had a higher BMI than those born second, according to Helen Briggs of BBC...

2014-02-06 23:23:31

Filmmakers Dan Finegold and Josh Eisenfeld have teamed with scientist and producer Dr. Dan Handley on a groundbreaking documentary that will chronicle the quest for what may be the first preventative therapy for Type 1 diabetes. Pittsburgh, PA (PRWEB) February 06, 2014 Official Project Website Type 1 diabetes affects over three million Americans, and is particularly devastating for the high proportion of children it afflicts. The disease is a type of autoimmune disorder where the body’s...

2014-02-06 23:02:31

Niche Publishing Leader Now Offers Five Wellness Titles BOSTON, MA (PRWEB) February 06, 2014 Madavor Media, LLC a specialty media company and one of the publishing industry’s fastest-growing providers of niche consumer content, has acquired Diabetic CookingTM magazine, which exclusively addresses diabetes control through dietary management and simple, healthful, recipes. This acquisition adds a fifth title to Madavor Media’s rapidly expanding Wellness division, which grew...

Diabetes Risk May Be Lower For Regular Consumers Of Yogurt And Low-Fat Fermented Dairy Products
2014-02-06 11:24:16

[ Watch the Video: Eat More Yogurt To Lower Diabetes Risk ] Brett Smith for redOrbit.com - Your Universe Online New research has shown that regular consumption of low-fat yogurt can reduce the risk of developing type 2 diabetes, according to a study published in the journal Diabetologia. The study researchers found that a higher consumption of low-fat fermented dairy products, which included some low-fat cheeses, cut the risk of type 2 diabetes onset by 28 percent and reduced the...

2014-02-06 08:29:38

-- Potentially transformative therapy for individuals with type 1 diabetes nearing major milestone -- NEW YORK and SAN DIEGO, Feb. 6, 2014 /PRNewswire/ -- JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D) research, and ViaCyte, Inc., a leading regenerative medicine company, jointly announced that JDRF is providing additional milestone-based funding for the continued development of ViaCyte's VC-01(TM) encapsulated cell therapy product candidate for the treatment...

2014-02-06 08:28:16

PHILADELPHIA, Feb. 6, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Robert F. Doman, Echo's Executive Chairman and Interim CEO, will participate in the Leerink Swann 2014 Global Healthcare Conference in New York, New York. Mr. Doman will make a corporate presentation to prospective corporate partners and...

2014-02-06 04:21:32

SAN DIEGO, Feb. 6, 2014 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today presented the results of a research study that demonstrated faster training times and fewer errors when using the t:slim Pump versus a leading insulin pump. These data were presented at the 7(th) Annual Advanced Technologies and Treatments for Diabetes (ATTD) International Conference in Vienna, Austria. (Logo:...

2014-02-05 08:29:34

FREMONT, Calif., Feb. 5, 2014 /PRNewswire/ -- Zosano Pharma, Inc. (Zosano) announced today that it has entered into an agreement with Novo Nordisk A/S (NYSE: NVO) to develop a new transdermal presentation of semaglutide, an investigational proprietary human GLP-1 (Glucagon-Like Peptide-1) analogue, to be administered once weekly using Zosano's microneedle patch system for the treatment of type 2 diabetes. Initially, Zosano and Novo Nordisk will engage in collaborative efforts to...

2014-02-04 16:27:53

DUBLIN, Feb. 4, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/5wg9cc/hemoglobin_a1c) has announced the addition of the "Concise Analysis of the International Hemoglobin A1c Testing Markets" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase...

2014-02-04 11:23:37

Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus, according to a study by Jeff D. Williamson, M.D., M.H.S., of the Wake Forest School of Medicine, Winston-Salem, N.C., and colleagues. Patients with type 2 diabetes (T2DM) are at increased risk for decline in cognitive function, for reduced brain volume and increased white matter lesions on brain imaging,...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »